Susquehanna International Group, LLP Zymeworks Inc. Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $152,213 - $243,213	-32,734 Reduced 15.26%	181,747 $1.12 Million
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.7 $428,020 - $683,767	88,801 Added 70.66%	214,481 $1.14 Million
Q1 2022 May 16, 2022	SELL	$6.0 - $16.98 $143,550 - $406,246	-23,925 Reduced 15.99%	125,680 $823,000
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $1.54 Million - $2.98 Million	101,519 Added 211.12%	149,605 $2.45 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $609,494 - $830,784	22,285 Added 86.37%	48,086 $1.4 Million
Q2 2021 Aug 11, 2021	SELL	$26.5 - $38.23 $1.14 Million - $1.65 Million	-43,082 Reduced 62.54%	25,801 $895,000
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $1.67 Million - $3.18 Million	55,917 Added 431.26%	68,883 $2.18 Million
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $918,381 - $1.29 Million	-23,476 Reduced 64.42%	12,966 $613,000
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $56,063 - $102,603	2,257 Added 6.6%	36,442 $1.66 Million
Q3 2019 Nov 14, 2019	SELL	$22.78 - $29.08 $60,822 - $77,643	-2,670 Reduced 7.24%	34,185 $848,000
Q2 2019 Aug 16, 2019	BUY	$15.0 - $22.49 $6,390 - $9,580	426 Added 1.17%	36,855 $811,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $22.49 $333,330 - $499,772	22,222 Added 156.42%	36,429 $801,000
Q4 2018 Feb 14, 2019	BUY	$10.95 - $15.44 $155,566 - $219,356	14,207 New	14,207 $209,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.